Article & News

Japan Drug Based on Gene Therapy Market Size, Strategic Outlook & Forecast 2026-2033Market size (2024): $5.2 billionForecast (2033):CAGR 2026-2033: 16.5%1.0 Strategic Assessment of Japan Drug

The pharmaceutical industry in the country has flagged the recent CDSCO’s norm mandating a minimum 60% shelf life for exported drugs as a significant hurdle,

Metabolic medicine dominated the health headlines in 2025 — and looks set to do so again in 2026.In 2025, GLP-1 weight-loss drugs, a new class

NEW DELHI: A citizen-funded quality study of commonly prescribed medicines has found no difference in quality between expensive branded drugs and the far cheaper generics,

The decision follows a proposal by the CDSCO, top internal advisory body-the Drugs Consultative Committee (DCC), which at its 67th meeting last month had also

Facing mount­ing scru­tiny over drug safety lapses, India is work­ing to over­haul its phar­ma­ceut­ical licens­ing frame­work by intro­du­cing a sep­ar­ate whole­sale licens­ing regime for bulk

At least 15 drug­makers are in the fray to tap the estim­ated ₹5,000 crore oppor­tun­ity emer­ging from sema­glu­tide’s pat­ent expiry, but the road to for­eign

The upward trajectory of weight-loss and diabetes drugs continues, as Eli Lilly’s Mounjaro clocks sales of over ₹100 crore in December 2025 – making it

More than 60% of India’s small and medium pharmaceutical enterprises (SMEs) face a potential shutdown by December 31, 2025, following non-compliance with revised Good Manufacturing

A leading thinker in the field of aging research, Dr. David Sinclair, shares insights on the rapid pace of advancements in aging research and predicts